Member Exclusive

First patient dosed in Japanese iPSC Parkinson’s trial

A patient in his 50s received iPSC-derived nerve cells to supplement dopamine-emitting neurons.

Go to the profile of Freya Leask
Nov 12, 2018

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.